Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Most new ventures don't last more than a decade. A few select companies survive and thrive for several decades. Fewer still go above and beyond by maintaining a healthy, growing dividend program throughout long periods; only incredibly strong companies can pull that off. If you're in the market for this type of investment, let's consider two excellent choices: Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) . These healthcare giants are passive income machines worth holding onto for good. 1. Abbott Laboratories Abbott Laboratories, a medical device specialist, has been raising its payouts for more than five decades: The company's streak of 51 consecutive annual increases makes it a Dividend King The secret behind Abbott's success is a steady, reliable, and predictable business. Physicians routinely use and prescribe its extensive portfolio of medical devices and diagnostic solutions for various conditions, some relatively benign, others life-threatening. Neit
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Christine Poole's Top Picks: CGI, Linde Pic and Microsoft [BNN Bloomberg (Canada)]BNN Bloomberg
- Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation [Seeking Alpha]Seeking Alpha
- Company News for Oct 17, 2024 [Yahoo! Finance Canada]Yahoo! Finance Canada
- Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Sanford C. Bernstein from $133.00 to $138.00. They now have an "outperform" rating on the stock.MarketBeat
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 10/21/24 - Form 144
- 10/16/24 - Form 8-K
- 10/1/24 - Form 4
- ABT's page on the SEC website